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concentrations approximating their physiologic concentration in cartilage.
As well, there is a differential inhibition of organic phosphatase, pyrophos-
phate hydrolase, and CPPD crystal dissolution activity by these amino
acids. In OA, there is a potential for bone ALP to be down regulated by
increasing the concentration of inhibiting amino acids or their analogues.
In CPPD, sequestration of inhibitory amino acids may permit sufﬁcient
ALP activity to facilitate CPPD crystal dissolution.
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Purpose: Among the matrix metalloproteinases (MMPs), MMP-13 plays
a major role in osteoarthritis (OA) due to its-rate limiting role in the
collagen degradation. MMP-13 expression is regulated by a variety of
transcription factors, including members of the ETS family such as ETS-2
and Elk-1, but the precise transcriptional mechanism is not completely
understood. ESE-1 is expressed in non-epithelial tissues after treatment
with inﬂammatory cytokines and we reported recently that ESE-1 re-
presses the type II collagen gene (COL2A1) in human chondrocytes.
These observations suggest a fundamental role of ESE-1 in cartilage
degeneration and suppression of repair. The aim of this study was to
determine whether ESE-1 participates in the MMP-13 transcriptional
regulation in chondrocytes.
Methods: The binding of in vitro-translated ESE-1 to the MMP-13 pro-
moter was analyzed by electrophoretic mobility shift assay (EMSA) and
supershift analysis. For knockdown of ESE-1 expression, the human
chondrocytic C-28/I2 cells were transfected with a pool of four individual
siRNA oligonucleotides against ESE-1 or control nonspeciﬁc siRNA. After
incubation for 72 hours, the knockdown was conﬁrmed by real time PCR
and Western blotting, and MMP-13 mRNA was analyzed by real time
PCR. MMP-13 protein in Ese1 (Elf3)-deﬁcient mice was addressed by
immunohistochemical staining.
Results: Three highly conserved ETS binding sites were revealed in
the proximal region of the MMP-13 promoter. By EMSA and supershift
analysis, we detected speciﬁc binding of ESE-1 to all three sites in the
proximal MMP-13 promoter, with stronger binding to the site containing
2 tandem ETS sites. These results suggested that ESE-1 could be
regulating the MMP-13 promoter activity. By using speciﬁc siRNA oligos,
we knocked down the ESE-1 expression in C28/I2 cells. Real time PCR
analysis revealed lower MMP-13 basal expression associated with ESE-1
knockdown. This result suggests that ESE-1 is necessary for maintaining
the MMP-13 basal expression levels. Finally, the immunohistochemical
analysis of the Elf3-deﬁcient mouse cartilage revealed low or unde-
tectable MMP-13 protein levels in comparison with age-matched wild type
cartilage samples, although type II collagen staining was similar with no
evidence of proteoglycan loss.
Conclusions: Our previous results highlighted ESE-1 as an important
transcriptional regulator of cartilage degenerative processes. After induc-
tion, ESE-1 transactivates both NOS2 and COX2 promoters by interacting
with NFúB. In addition, we showed recently that ESE-1 represses the
COL2A1 in human chondrocytes and that ESE-1 immunostaining is high
in human OA cartilage, whereas it is not present or undetectable in
control cartilage. In this work we show that ESE-1 binds directly to the
MMP-13 proximal promoter region and that knocking down the ESE-1
expression leads to decreased MMP-13 basal expression levels. These
results suggest that, among others, ESE-1 is a key factor for maintaining
the MMP-13 basal expression. Moreover, our ﬁnding that MMP-13 protein
levels are decreased or absent in the cartilage of Elf3-deﬁcient mice
further reinforces the role of the ESE-1 in maintaining MMP-13 basal
expression. However, the lack of evidence of collagen degradation in
wild type samples indicates that activation of the proenzyme requires
additional stimuli. Altogether, our results suggest a fundamental role for
ESE-1 in controlling MMP-13 gene expression in chondrocytes. Further
work will be required to determine its role in progressive cartilage loss
during OA.
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Purpose: Increased subchondral bone thickness, altered bone mineral
density distribution, and trabecular microfractures are characteristic mor-
phologic features of osteoarthritis. However on the microscopic scale,
(mm), the bone mineralization patterns remain to be elucidated. To
develop a better understanding of subchondral bone mineralization in
osteoarthritis and to explore the utility of high voltage, high resolution
x-ray microscopy in resolving bone structure, we studied the articular
bone plate and subchondral bone trabeculae in ten cases of osteoarthritis
using CPPD crystal deposition disease and osteoporosis cases as control
tissues.
Methods: Five mm coronal blocks were taken from the femoral condyles
at cross sections where osteoarthritis was maximal and where articular
cartilage was still present. These blocks were adjacent to blocks taken
for routine diagnostic analysis. The formalin-ﬁxed blocks were studied
using a Comet Feinfocus 160.25 x-ray microscopy system (focal spot
<1mm). For this study, magniﬁcation was set at the highest practical level
to obtain clear images, projection magniﬁcation = 28×. X-ray exposures
were optimized to characterize the bone mineral structure (80 kV, 45 uA).
Magniﬁcation was calibrated using a copper electron microscope grid
diameter = 3mm, with grid line width = 35 mm.
Results: Samples clearly showed resolution of features less than 10 mm
in width and demonstrated different mineralization density within bone
structures. Figure 1 shows a sample range of the initial morphologic
observations. The osteoporosis control, Fig. 1.3 shows subchondral bone
with similar density to that of the bone trabeculae (bars) as well as ex-
tensive but focal, trabecular microfractures with increased mineralization
(arrow). Samples from osteoarthritis patients, Fig. 1.2 and 1.3, demon-
strated increased bone mineral density within the subchondral plate.
However, Fig. 1.3 showed extensive trabecular microfractures with highly
mineralized density compared to normal trabeculae whereas Fig. 1.2
did not. In Fig. 1.4 from the calcium pyrophosphate crystal deposition
disease, the image shows a morphologic pattern more closely resembling
osteoporosis Fig. 1.3 than osteoarthritis.
Conclusions: These studies show that X-ray microscopy is a promising
tool to delineate subsets of subchondral bone response in osteoarthritis.
The observations conﬁrm that subchondral osteosclerosis in osteoarthritis
is related to increased bone mineral density of the subchondral bone plate
irrespective of bone thickness. However, trabecular microfractures with
increased mineralization density occurs only in a portion of patients with
osteoarthritis. This indicates that the subchondral bone trabecular struc-
ture and mineralization distribution in osteoarthritis is heterogeneous.
Most likely, this reﬂects different types of osteoarthritis with differential
bone mineralization response, rather than different stages of the disease.
Figure 1.
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Purpose: Research in osteoarthritis (OA) has in recent years suggested a
relationship between chondrocyte telomere length and severity of OA. We
